BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20705080)

  • 1. Epigenetic modifications in valproic acid-induced teratogenesis.
    Tung EW; Winn LM
    Toxicol Appl Pharmacol; 2010 Nov; 248(3):201-9. PubMed ID: 20705080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity.
    Menegola E; Di Renzo F; Broccia ML; Prudenziati M; Minucci S; Massa V; Giavini E
    Birth Defects Res B Dev Reprod Toxicol; 2005 Oct; 74(5):392-8. PubMed ID: 16193500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects.
    Tung EW; Winn LM
    Mol Pharmacol; 2011 Dec; 80(6):979-87. PubMed ID: 21868484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
    Dawson JE; Raymond AM; Winn LM
    Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPA-related axial skeletal defects and apoptosis: a proposed event cascade.
    Di Renzo F; Broccia ML; Giavini E; Menegola E
    Reprod Toxicol; 2010 Jan; 29(1):106-12. PubMed ID: 19850124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid-induced DNA damage increases embryonic p27(KIP1) and caspase-3 expression: a mechanism for valproic-acid induced neural tube defects.
    Tung EW; Winn LM
    Reprod Toxicol; 2011 Nov; 32(3):255-60. PubMed ID: 21708246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
    Okada A; Kushima K; Aoki Y; Bialer M; Fujiwara M
    Birth Defects Res A Clin Mol Teratol; 2005 Apr; 73(4):229-38. PubMed ID: 15799026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational valproic acid exposure induces epigenetic modifications in murine decidua.
    Shafique S; Winn LM
    Placenta; 2021 Apr; 107():31-40. PubMed ID: 33735658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone modifications at the blastocyst Axin1(Fu) locus mark the heritability of in vitro culture-induced epigenetic alterations in mice.
    Fernandez-Gonzalez R; Ramirez MA; Pericuesta E; Calle A; Gutierrez-Adan A
    Biol Reprod; 2010 Nov; 83(5):720-7. PubMed ID: 20650886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells.
    Jergil M; Forsberg M; Salter H; Stockling K; Gustafson AL; Dencker L; Stigson M
    Toxicol Sci; 2011 Jun; 121(2):328-42. PubMed ID: 21427059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V; Wlodarczyk B; Giavini E; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes.
    Milutinovic S; D'Alessio AC; Detich N; Szyf M
    Carcinogenesis; 2007 Mar; 28(3):560-71. PubMed ID: 17012225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid-induced somite teratogenesis in the chick embryo: relationship with Pax-1 gene expression.
    Barnes GL; Mariani BD; Tuan RS
    Teratology; 1996 Aug; 54(2):93-102. PubMed ID: 8948545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiment study of PHI on histone methylation and acetylation in Molt-4 cells].
    Huang YQ; Ma XD; Zhen RJ; Chiao JW; Liu DL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):612-5. PubMed ID: 18246819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
    Eikel D; Lampen A; Nau H
    Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
    Godino A; Jayanthi S; Cadet JL
    Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture.
    Bruckner A; Lee YJ; O'Shea KS; Henneberry RC
    Teratology; 1983 Feb; 27(1):29-42. PubMed ID: 6405496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione.
    Hishida R; Nau H
    Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.